PanAgora Asset Management »

Stoke Therapeutics shares owned by PanAgora Asset Management

Quarter-by-quarter ownership of Stoke Therapeutics (STOK) shares owned by PanAgora Asset Management from 13F filings

Historical chart of PanAgora Asset Management investment in Stoke Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Stoke Therapeutics held by PanAgora Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Stoke Therapeutics by PanAgora Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 104k 11.03

More positions owned by PanAgora Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Amazon (AMZN)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Mastercard Incorporated Cl A (MA)
Palantir Technologies Cl A (PLTR)
Philip Morris International (PM)
Arista Networks Com Shs (ANET)
Booking Holdings (BKNG)

View all positions for PanAgora Asset Management

Top funds holding Stoke Therapeutics

FMR
BlackRock
Lynx1 Capital Management
Rtw Investments
Baker Bros. Advisors
Redmile Group
Morgan Stanley
Toronto-Dominion Bank
Vanguard Group
Skorpios Trust
Siren
BVF
State Street Corporation
Polar Capital Holdings
Point72 Asset Management

View all funds holding Stoke Therapeutics